PharmaResearch Hosts Global Symposium Uniting Clinicians From 64 Nations
The PharmaResearch Global Symposium: Uniting Innovators in Regenerative Medicine
In a remarkable gathering held from October 26 to 28, 2026, in Gangneung, South Korea, PharmaResearch brought together over 750 clinicians from 64 countries for the seventh edition of its Global Symposium. The event highlighted the latest advancements in aesthetic and regenerative medicine, particularly featuring the acclaimed skin booster, REJURAN.
The symposium serves as an essential platform for healthcare professionals to exchange knowledge and experiences surrounding the innovative use of polynucleotides (PN) and polydeoxyribonucleotides (PDRN) in clinical practices. Through a series of informative sessions and discussions, attendees gained insights into emerging treatment methods and shared their clinical experiences with these advanced biological treatments.
Unveiling the Science Behind REJURAN
The symposium's agenda included an in-depth exploration of how PharmaResearch sources and processes the raw materials essential for its products. Attendees were taken on a guided tour to a facility operated by the Korea Fisheries Resources Agency, where they witnessed the harvesting of vital components from wild salmon, which is foundational to the production of PN and PDRN. This tour also showcased PharmaResearch's state-of-the-art production facility in Gangneung, illustrating the stringent quality control measures in place.
The scientific program kicked off with an emphasis on the safety profiles associated with REJURAN. Renowned U.S. physician Dr. Suneel Chilukuri presented a thorough evaluation of REJURAN's safety, while fellow researchers from Thailand, Drs. Atchima Suwanchinda and Thanya Techapichetvanich, contributed their recent findings on PN across various treatment areas. The discussions also delved into the tissue-level interactions of PN, guided by Dr. Steven Liew from Australia, who shared histological insights into how these treatments may aid in skin repair and rejuvenation.
Clinical case studies were a fundamental part of the discussions, with presentations from Dr. Yuri Yogya in Indonesia, focusing on lip treatment cases, and Dr. Soichiro Morikawa from Japan, who elaborated on synergistic treatment experiences combining PN with additional therapies. These cases offered a real-world context to the theoretical frameworks discussed throughout the symposium.
The Role of Public Figures in Promoting Beauty
Prominent South Korean actress Kim Sejeong, a global ambassador for both REJURAN and REJURAN COSMETICS, attended the symposium and shared her enthusiasm for the event. “It was an honor to be part of an event that brought together so many clinicians and researchers from around the world,” she remarked. “I hope to extend REJURAN's message about nurturing your natural beauty and boosting self-confidence to a broader audience.”
PharmaResearch representatives expressed optimism about the symposium's contributions to medical aesthetics, stating, “The symposium provided a unique opportunity for clinicians worldwide to review clinical evidence and safety data for our DOT® PN products. Discussions like these are vital for shaping future treatment protocols, and we are eager to expand these exchanges both in South Korea and internationally.”
About PharmaResearch
PharmaResearch is a pioneering South Korean biopharmaceutical company that focuses on enhancing quality of life through regenerative medicine. Its diverse portfolio includes medicines, medical devices, cosmetics, and health supplements, all centered around proprietary DOT® PDRN and DOT® PN technologies that are safeguarded by numerous patents. Headquartered in Gangneung, PharmaResearch is the driving force behind REJURAN, its globally recognized PN-based skin booster, which is available now in over 50 countries, alongside REJURAN COSMETICS, its premium dermo-cosmetic line.
The success of the PharmaResearch Global Symposium marks another significant milestone in the company's mission to advance regenerative medicine and set new standards in aesthetic treatments worldwide.